Trial Profile
A randomized, double-blind, RCT study of perioperative administered intravenous parecoxib: Effect on postoperative pain and local inflammation factors PGE2 and IL-6 for total knee arthroplasty.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 24 Apr 2016
Price :
$35
*
At a glance
- Drugs Parecoxib (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- Sponsors Pfizer
- 01 Sep 2010 New trial record